Enrollment has begun in an early-stage clinical trial evaluating phage therapy (bacteriophage) in adults with cystic fibrosis who carry Pseudomonas aeruginosa in their lungs.
Category: Cystic fibrosis
A study published in the American Journal of Respiratory and Critical Care Medicine investigated how increased vigorous physical activity impacted lung function for sedentary patients with cystic fibrosis.Read More
The FDA has granted orphan drug designation to the SpliSense cystic fibrosis drug SPL84-23, an ASO (antisense oligonucleotide).Read More
A Swiss study recently published in Respiration found that bronchodilator inhalation with salbutamol is likely to have a positive short-term effect on forced expiratory volume in pediatric patients with cystic fibrosis.Read More
The Cystic Fibrosis Foundation is investing $3.5 million for the development of Pulmocide’s inhaled drug to prevent pulmonary aspergillosis infection in lung transplant recipients.Read More
A multidisciplinary research team at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a microfluidic organ chip device the size of a USB memory stick that recapitulates key pathological hallmarks from CF patients.Read More
Children with cystic fibrosis are at an increased risk of obstructive sleep apnea, new research has found.Read More